2C TECH

2C Tech is leveraging unique expertise in nanoparticle technologies for the creation of innovative therapeutic approaches for the treatment of ophthalmic diseases and conditions. The Company’s immediate focus is on the development of a proprietary therapy for patients with retinal degenerative conditions, for whom no effective treatment is currently available. While initially focused on Retinitis Pigmentosa (RP), the 2C Tech approach could also have positive benefits in certain forms of Macular Degeneration, Glaucoma and Diabetic Retinopathy, where patient populations are far greater.